BlueWhale Bio
PrivateLast Round
VC Round
Oct 16, 2025
Total Funding Raised
$18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BlueWhale Bio is a biotechnology company that develops cell-derived nanoparticle platforms to improve the manufacturing efficiency and accessibility of cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlueWhale Bio Comparables
Compare BlueWhale Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sartorius Aktiengesellschaft | 77% | |
| Miltenyi Biotec | 77% | |
| Thermo Fisher Scientific Inc. | 74% |
BlueWhale Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 16, 2025 | ||||
| Seed | Sep 7, 2023 |
BlueWhale Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Seed |
| Danaher Ventures | Seed |
| Novalis LifeSciences | Seed |
| Marshall Wace | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 42% MoM.
- Aug 21, 2026
Monthly visitors grew 154% MoM, reaching 2.4K.
Recent news
Latest coverage and updates
- attends_eventOct 5, 2026
BlueWhale Bio, Inc. plans to present at the Cell & Gene Meeting on the Mesa
BlueWhale Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BlueWhale Bio's valuation, stock price, and market status.
Is BlueWhale Bio a public or private company?
BlueWhale Bio is a private company.
What is the current stock price of BlueWhale Bio?
BlueWhale Bio is a private company, so its shares have no public market price. Caplight tracks BlueWhale Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BlueWhale Bio worth (valuation)?
Valuation information for BlueWhale Bio is not publicly available.
Can I buy BlueWhale Bio stock?
BlueWhale Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BlueWhale Bio's last funding round?
BlueWhale Bio's most recent funding round was VC Round on October 16, 2025.
Who are the main investors in BlueWhale Bio?
Key investors in BlueWhale Bio include Danaher Ventures.
Will BlueWhale Bio IPO soon?
No public IPO plans have been announced for BlueWhale Bio.
How can I track BlueWhale Bio secondary market activity?
Caplight tracks bids, offers, and trades in BlueWhale Bio's shares on secondary markets.